A Endothelium-derived extracellular vesicles promote splenic monocyte mobilisation in myocardial infarction

BackgroundFollowing acute myocardial infarction (AMI), monocytes are rapidly mobilised from the spleen to peripheral blood, from where they undergo transcriptional activation and infiltrate injured tissue, with potential to contribute to both injury and repair. The mechanism by which the injured myo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart (British Cardiac Society) 2017-06, Vol.103 (Suppl 5), p.A150-A150
Hauptverfasser: Akbar, Naveed, Digby, Janet E, Cahill, Thomas J, Tavare, Abhijeet N, Saluja, Sushant, Dawkins, Sam, Edgar, Laurienne, Rawlings, Nadia, Ziberna, Klemen, McNeill, Eileen, Johnson, Errin, Aljabali, Alaa A, Dragovic, Rebecca A, Rohling, Mala, Grant Belgard, T, Greaves, David R, Channon, Keith M, Riley, Paul R, Anthony, Daniel C, Choudhury, Robin P
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundFollowing acute myocardial infarction (AMI), monocytes are rapidly mobilised from the spleen to peripheral blood, from where they undergo transcriptional activation and infiltrate injured tissue, with potential to contribute to both injury and repair. The mechanism by which the injured myocardium signals splenic-monocyte mobilisation remains poorly understood. Recent work shows extracellular vesicles (EV, which carry proteins, microRNA/mRNA) are a means of rapid cell-to-cell communication, which, combined with knowledge of their composition and propensity to be taken up by other cells, suggests a possible role in signalling. Here we show that AMI results in a net increase in circulating endothelial cell (EC)-EV that induce splenic monocyte motility in vivo and cellular transcription.MethodsPlatelet-poor plasma was collected from patients with ST-segment elevation-AMI (STEMI) and mice subjected to AMI. EV were isolated by ultra-centrifugation and analysed for size/number by Nanoparticle Tracking Analysis, western blot (EV-markers: ALIX, TSG101, CD69, CD9 and Hsp70), ELISA for EC markers (CD31, ICAM-1, P-selectin, E-selectin and VCAM-1), electron microscopy and for EV-miRNAs. Human and mouse EC were used in vitro to evaluate EV release, injected into wild-type or CD68GFP+ naïve mice to assess bio-distribution, splenic-monocyte mobilisation, uptake by monocytes, cellular mRNA transcription and cell motility.ResultsAcutely (24 hours) after AMI there is a significant increase in circulating EV in humans (p
ISSN:1355-6037
1468-201X
DOI:10.1136/heartjnl-2017-311726.232